Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Staar Surgical ( (STAA) ) has shared an announcement.
On May 13, 2026, STAAR Surgical reported record first‑quarter 2026 net sales of $93.5 million, up 119.6% year over year, driven largely by a recovery in China and strong U.S. growth, and returned to profitability with net income of $5.2 million after a loss a year earlier. The company highlighted normalized distributor inventories and robust demand for EVO+ ICL in China, expanding FDA indications and double‑digit growth in the U.S., and ongoing efficiency initiatives in Swiss manufacturing and ERP rollout, positioning it for sustained, profitable growth amid a global shift toward lens‑based refractive surgery.
The most recent analyst rating on (STAA) stock is a Hold with a $22.00 price target. To see the full list of analyst forecasts on Staar Surgical stock, see the STAA Stock Forecast page.
Spark’s Take on STAA Stock
According to Spark, TipRanks’ AI Analyst, STAA is a Neutral.
Overall score is held back primarily by deteriorated profitability and cash flow (including negative operating/free cash flow), despite balance-sheet strength and very high gross margins. Technicals are supportive of an uptrend but look overbought, while valuation is constrained by losses. Recent commentary and updates point to improving operations and a push toward FY2026 profitability, but execution and channel/regional volatility remain key risks.
To see Spark’s full report on STAA stock, click here.
More about Staar Surgical
STAAR Surgical Co., based in Lake Forest, California, is a medical device company specializing in lens‑based refractive surgery. It is a global leader in phakic implantable collamer lenses, marketed under the EVO and EVO+ ICL brands, which offer an alternative to laser eye procedures and target growing demand for myopia and astigmatism correction, particularly in markets such as China and the U.S.
Average Trading Volume: 1,270,379
Technical Sentiment Signal: Buy
Current Market Cap: $1.4B
See more insights into STAA stock on TipRanks’ Stock Analysis page.